Showing results (291-300 of 847) with videos related to
Sort By:
Pageof 85
Journal of Psychiatric Research|November 28, 2022
Haematological point of care testing for clozapine monitoringMatthew Atkins, Philip McGuire, Bhirundra Balgobin, et al.Journal of Substance Abuse Treatment|February 26, 2008
Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse eventsSuzanne Nielsen, Paul Dietze, Kate Cantwell, et al.The Annals of Thoracic Surgery|January 29, 2008
Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantationMichael J Bates, Emily Farkas, David Taylor, et al.Journal of Psychopharmacology (Oxford, England)|February 25, 2005
Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugsDavid Taylor, Corina Young, Radia Mohamed, et al.Addiction (Abingdon, England)|February 9, 2007
Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatmentSuzanne Nielsen, Paul Dietze, Nicole Lee, et al.Therapeutic Advances in Psychopharmacology|August 29, 2013
Bipolar depression: clinically missed, pharmacologically mismanagedLisa C Lloyd, Giovanni Giaroli, David Taylor, et al.Bioinspiration & Biomimetics|December 19, 2015
Buckling failures in insect exoskeletonsEoin Parle, Simona Herbaj, Fiona Sheils, et al.Veterinary and Comparative Oncology|January 10, 2020
Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumoursAntony S Moore, Angela E Frimberger, David Taylor, et al.Therapeutic Advances in Psychopharmacology|February 3, 2022
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature reviewEbenezer Oloyede, Ivana Clark, Shubhra Mace, et al.International Journal of Psychiatry in Clinical Practice|June 18, 2014
Buccal midazolam for agitation on psychiatric intensive care wardsDavid Taylor, Chike Okocha, Carol Paton, et al.Pageof 85